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Objective: Patients with bicuspid aortic valve are at increased risk for aortic compli-
cations.
Methods:A total of 115 consecutive patients with bicuspid aortic valve disease under-
went surgery of the ascending aorta. We classified the cusp configuration by 3 types:
fusion of left coronary and right coronary cusps (type A), fusion of right coronary and
noncoronary cusps (type B), and fusion of left coronary and noncoronary cusps (type
C). Histopathologic changes in the ascending aortic wall were graded (aortic wall
score).
Results: We observed type A fusion in 85 patients (73.9%), type B fusion in 28 pa-
tients (24.3%), and type C fusion in 2 patients (1.8%). Patients with type A fusion
were younger at operation than patients with type B fusion (51.3 6 15.5 years vs
58.7 6 7.6 years, respectively; P 5 .034). The mean ascending aorta diameter was
48.96 5.0 mm and 48.76 5.7 mm in type A and type B fusion groups, respectively
(P5 .34). The mean aortic root diameter was significantly larger in type A fusion (4.9
6 6.7 mm vs 32.7 6 2.8 mm; P , .0001). The aortic wall score was significantly
higher in type A fusion than in type B fusion (P 5 .02). The prevalence of aortic
wall histopathologic changes was significantly higher in type A fusion. Moreover,
there were no statistically significant differences between type A and type B fusion
in terms of prevalence of bicuspid aortic valve stenosis, regurgitation, or mixed
disease.
Conclusion: In diseased bicuspid aortic valves, there was a statistically significant as-
sociation between type A valve anatomy and a more severe degree of wall degener-
ation in the ascending aorta and dilatation of the aortic root at younger age compared
with type B valve anatomy.
B
icuspid aortic valve (BAV) is one of the most common congenital diseases
involving the heart valves, with a prevalence ranging from 1% to 2% of the
entire population. More important, it is associated with an increased lifelong
risk of aortic valve dysfunction and endocarditis, requiring surgery.1 Furthermore,
data from several groups, including our own,2-4 demonstrated that patients with
BAV are at increased risk for aortic complications, even late after aortic valve surgery,
because of histopathologic changes in the ascending aorta, predisposing one to aneu-
rysm development and dissection.5-7
The aim of the study is to investigate the relationships between aortic valve anat-
omy and histopathology of the aortic wall in a series of patients affected by BAV and
undergoing replacement of the ascending aorta.
Materials and Methods
Study Group
After authorization from the hospital review board, we reviewed our computerized database and
identified 115 consecutive patients who underwent surgery on both the BAV and the ascending
aorta between January of 2003 and November of 2006 at the Niguarda Ca` Granda Hospital. We
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did not include patients who underwent isolated surgery of the aortic
valve without resection and histologic examination of the ascending
aorta or patients undergoing surgery for type A aortic dissection.
The mean age was 55.2 6 15.6 years (range: 12–80 years), the
mean body surface area was 1.81 6 0.24 m2 (range: 1.6–2.2 m2),
and 18 patients (15.6%) were female. All patients were affected
by BAV severe stenosis, regurgitation, or a combination of both
that required concomitant valve replacement or repair. No patients
were affected by frank Marfan syndrome, according to Ghent crite-
ria,8 or had a history of rheumatic heart disease.
Anatomic Definition of Bicuspid Aortic Valve
The diagnosis of BAV was made preoperatively by means of 2- or
3-dimensional transthoracic echocardiography. The diagnosis was
confirmed during intraoperative surgical inspection of the aortic
valve, according to previous anatomic descriptions.9,10We reviewed
operative reports for all patients to obtain the pattern of cusp fusion
and aortic diameter. The position of any raphe was recorded.
Ascending Aorta and Aortic Root Diameters
Transverse diameter of both the mid-ascending aorta above the sino-
tubular junction and the aortic root at the Valsalva sinuses were mea-
sured in all patients both preoperatively (by means of computed
tomography and echocardiography) and during the operation (by
means of direct measurement and transesophageal echocardiogra-
phy). We recorded the highest measured diameter.
Indications to the Operation
In 2001, after the observation of increased incidence of aortic com-
plications at long-term after BAV surgery,2 we adopted an aggres-
sive policy to replace dilated ascending aortas or aortic roots in
patients with BAV. The threshold diameter to replace the aorta is be-
tween 40 and 45 mm, according to clinical status and surgeon pref-
erence. In case of significant displacement of the coronary ostia from
the aortic anulus, we replaced the entire aortic root by implantation
of a composite valved-graft (modified Bentall technique) or by
a valve-sparing operation, according to cusp status and surgeon
preference. We elected to perform a Ross operation only in children.
Histopathologic Examination
Circumferential aortic wall samples, from themid-ascending aorta at
the point of maximal dilatation, were fixed in formalin for 24 hours.
The tissue was processed for light microscopy and embedded in par-
affin blocks, and sections were taken from each specimen. Sections
were stained with hematoxylin-eosin and Masson trichrome stains.
In all cases, histologic examination was performed in an unblinded
way by one of the authors (E.B.) along the full length of the circum-
ferential aortic wall samples. Histopathologic changes were graded
according to criteria published by Matthias Bechtel and coworkers.5
In brief, 7 pathologic features of the aortic wall, namely, fibrosis, ath-
erosclerosis, medionecrosis, cystic medial necrosis, smooth muscle938 The Journal of Thoracic and Cardiovascular Surgery c Octcell orientation, elastic fragmentation, and inflammation, were
analyzed in each specimen and graded using a scale from 0 (no path-
ologic changes) to 3 (most severe changes). Grading was determined
on the basis of the worst area observed. The sum of the results of all
variables was calculated in each patient, and this is the aortic wall
score (AWS).
Statistical Analysis
Categoric variables are expressed as total numbers and percentages.
Continuous variables are expressed as means6 standard deviation.
In case of continuous nonparametric variables, as shown by the Kol-
mogorov–Smirnov test, we reported data as median and interquartile
range. Comparison of categoric variables was performed with the
chi-square test or Fisher’s exact test, as appropriate, and continuous
variables were analyzed with the Student t test or Mann–Whitney
test, as appropriate.
Results
Overall Population
In all cases, we observed only 1 raphe in each aortic valve.
Therefore, we classified BAV anatomy in 3 types according
to raphe orientation in relation to the sinuses and cusp fusion
pattern (Figure 1): fusion of left coronary and right coronary
cusps (type A), fusion of right coronary and noncoronary
cusps (type B), and fusion of left coronary and noncoronary
cusp (type C). We observed type A fusion in 85 patients
(73.9%), type B fusion in 28 patients (24.3%), and type C fu-
sion in 2 patients (1.8%) (Figure 1). Because of the low prev-
alence of type C fusion in this series, we elect to exclude it
from further comparisons with the other 2 patterns. The
mean ascending aorta diameter was 49.5 6 8.9 mm (range
38–80 mm). The aortic root diameter at the Valsalva sinuses
Figure 1. Shaded area shows the position of the raphe on the
valve. LC-NC, Left coronary-noncoronary cusp; LC-RC, left coro-
nary-right coronary cusp; RC-NC, right coronary-noncoronary
cusp.ober 2008
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was 7.86 4.4 (range 3–21). There was a correlation between
ascending aorta diameter and AWS (r5 0.5723) in our series
of patients affected by both BAV disease and aortic aneurysm
(Figure 2). The surgical procedures are shown in Table 1. The
in-hospital mortality was 1.7% (2/115).
Comparisons Between Type A and Type B Fusion
Comparisons between type A and type B fusion are reported
in Table 2. Patients with type A fusion were younger at oper-
ation than patients with type B fusion (mean age 51.36 15.5
years vs 58.7 6 7.6 years, respectively, P 5 .034; median
age 52 vs 61 years, respectively; range 16–74 years vs
44–75 years, respectively). The mean ascending aorta diam-
eter did not differ significantly between type A and type B
groups. However, in type A the mean aortic root diameter
was significantly larger (P , .0001). Moreover, there were
no statistically significant differences between type A fusion
and type B fusion in terms of prevalence of BAV stenosis, re-
gurgitation, mixed disease, and arterial hypertension. Median
(interquartile range) AWS was significantly higher in type A
fusion than in type B fusion (6 [3–9] vs 3 [1–4], P , .001).
The prevalence of fibrosis, medionecrosis, cystic medial ne-
crosis, smooth muscle cell orientation, elastic fragmentation,
and inflammation (grade $ 1) was significantly higher in
type A fusion compared with type B fusion (Table 3).
However, we did not observe any statistically significant
difference in terms of atherosclerosis. Figure 3 shows histo-
logic sections from the ascending aorta of patients with
type A anatomy and patients with type B anatomy.
Discussion
Anatomic and Histopathologic Evidence
The main observations derived from the study on patients
affected by both BAV disease and aortic dilatation are as
follows:
Figure 2. Correlation between ascending aorta diameter and AWS
in patients with BAV.The Journal of Tho1. Type A cusp fusion is the most common configuration
observed in BAV, followed by type B.
2. Type A cusp fusion is associated with a more severe
degree of degeneration of the ascending aorta wall,
even in the absence of significant differences with
type B group in terms of ascending aorta diameter,
BAV disease, and prevalence of arterial hypertension;
nevertheless, the mean age of patients with type A was
significantly lower than that of patients with type B.
Moreover, in type A fusion the aortic root diameter
was significantly larger than in type B fusion.
3. The degree of aortic wall degeneration is directly
related to the ascending aorta diameter.
Our anatomic data confirm previous evidence on the
configuration of aortic valve cusps in BAV. In a surgical pa-
thology study including 542 cases of BAV, Sabet and co-
workers10 reported a prevalence of 86% for type A fusion,
compared with 12% for type B. In an echocardiographic
TABLE 1. Surgical techniques
n %
Combined AVR and ascending
aorta replacement
29 25.2
Combined AVRep and ascending
aorta replacement
1 0.9
Modified Bentall operation 79 68.7
David operation 5 4.3
Ross operation 1 0.9
Other combined procedures
AF surgery 1
CABG 16
MVR 6
ASD repair 1
AVR, Aortic valve replacement; AVRep, aortic valve repair; AF, atrial fibrilla-
tion; CABG, coronary artery bypass grafting;MVR, mitral valve replacement;
ASD, atrial septal defect.
TABLE 2. Features of type A and type B cusp fusion
Type A
N 5 85
Type B
n 5 28 P
Ascending aorta
diameter, mean 6 SD
48.9 6 5.0 mm 48.7 6 5.7 mm NS
Aortic root
diameter, mean 6 SD
44.9 6 6.7 mm 32.7 6 2.8 mm ,.0001
Age, mean 6 SD 51.3 6 15.5 y 58.7 6 7.6 y .034
AWS, median
(interquartile range)
6.0 (3–9) 3.0 (1–4) ,.001
Stenotic BAV 41.1% 32.1% NS
Regurgitant BAV 41.1% 46.4% NS
Mixed disease BAV 16.4% 21.4% NS
Arterial hypertension 27.0% 25.0% NS
SD, Standard deviation; AWS, aortic wall score; BAV, bicuspid aortic valve;
NS, not significant.racic and Cardiovascular Surgery c Volume 136, Number 4 939
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observed a prevalence of 70% and 28% for type A and
type B fusion, respectively. Moreover, in both articles10,11
type C was the least common morphologic variant. Sievers
and Schmidtke12 recently proposed a classification system
for BAV based on the number of raphes. In the present series,
we observed BAV with only 1 raphe (Sievers type 1) in all
cases. In Sievers series, type 1 BAV accounted for 88% of
cases and the distribution of cusp fusion patterns was compa-
rable to our observations.
Histopathologic changes in the ascending aorta, predis-
posing one to aneurysm development and dissection, are
well documented in BAV.5-7 The results from our series con-
firm the presence of pathologic alterations in the wall of the
ascending aorta. Moreover, we observed that the severity
of changes in the aortic wall relates to the degree of aortic di-
latation, as reported by Matthias Bechtel and coworkers.5
It has been suggested that a relationship exists between
BAVmorphology and different cardiac abnormalities, valvar
function, and aortic root dilation.11 Aortic stenosis or regur-
TABLE 3. Histopathologic changes in ascending aorta wall
in type A and type B cusp fusion
Histopathologic change
Type A
N 5 85
Type B
n 5 28 P
Fibrosis 67.0% 21.4% #.01
(0.9) (0.2)
Atherosclerosis 56.4% 42.8% NS
(1.0) (0.7)
Medionecrosis 80.0% 42.8% ,.025
(1.7) (0.9)
Cystic medial necrosis 90.5% 57.1% ,.025
(2.1) (1.0)
SMC orientation 67.0% 35.7% #.01
(0.7) (0.3)
Elastic fragmentation 83.5% 50.0% ,.025
(0.8) (0.4)
Inflammation 27.0% 7.1% #.05
(0.3) (0.1)
NS, Not significant; SMC, smooth muscle cell. Numbers in parentheses
show mean grading value for each histopathologic feature.940 The Journal of Thoracic and Cardiovascular Surgery c Octgitation is observed most often in patients with type B cusp
fusion, whereas the majority of patients with aortic coarcta-
tion and a lesser degree of valve disease had type A fusion.11
These observations were recently confirmed by Ciotti and
coworkers.13 To the best of our knowledge, the association
between coronary cusps fusion and a more severe degree of
degeneration of the ascending aorta is a novel finding. We
did not observe a statistically significant difference between
type A and type B cusp configurations in terms of ascending
aorta diameter, BAV disease, and known risk factors for aor-
tic degeneration, such as arterial hypertension. However,
mean age was significantly lower in the type A fusion group.
Therefore, it can be argued that the more severe aortic wall
degeneration observed in type A configuration is not related
to the degree of ascending aorta dilatation or to other known
factors. Nevertheless, the aortic root diameter was within the
normal range in type B fusion, whereas it was significantly
larger in type A fusion. Such a difference may suggest a het-
erogeneous localization of aortic disease among cusp fusion
patterns. This finding deserves further study by examining
tissue samples from the Valsalva sinuses.
The pathogenesis of aortic dilatation in patients with BAV
is still unclear. Moreover, it is controversial if such a mecha-
nism is related to intrinsic congenital defects or to an acquired
injury resulting from the ascending aorta wall being second-
ary to BAV flow patterns. It has been speculated that the as-
sociation between cusp arrangement and ascending aorta
disease may be explained by abnormal patterns of develop-
ment of the neural crest cells, which contributes to the em-
bryogenesis of both cardiac structures,14,15 or by a peculiar
hemodynamic effect of each BAV anatomic type, acting
since fetal life and resulting in different degrees of stress-in-
duced aortic degeneration. Cotrufo and coworkers7 reported
an asymmetric pattern of matrix protein expression in BAV-
associated aortic dilatation, consistent with the asymmetry in
wall-stress distribution, and differences between patients
with stenotic BAV compared with regurgitant BAV in terms
of protein expression and content in the aortic wall.
The finding that patients with type A fusion had a more se-
vere aortic wall degeneration compared with patients with
type B fusion, despite similar aortic size, has severalFigure 3. A, Histologic section from the
ascending aorta in a patient with type A
valve anatomy (AWS 8): severe cystic
medial necrosis, grade 3 (circled area),
and fragmentation of elastic fibers. B,
Histologic section from the ascending
aorta in a patient with type B valve anat-
omy (AWS 3): fibrosis, fragmentation of
elastic fibers, and misalignment of
smooth muscle cells. Five-micron sec-
tions, Masson trichrome elastic stain,
magnification 1003.ober 2008
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the result of the correlation analysis greater than type B group
data. It is likely that this is related to the different sample size
in the 2 groups. The type B group was small; consequently,
a correlation analysis only on type B data was not so informa-
tive. We hypothesize that the correlation between diameter
and AWS may be different between type A and type B.
Such a difference could be explained by a still unknown
factor, acting on the status of the aortic tissue and related to
developmental mechanisms that determine the anatomy of
the BAV.
Clinical Implications
Data from different groups2,4 demonstrated that patients with
BAV are at increased risk for aortic complications and that
aortic valve replacement does not prevent progressive aortic
dilatation.4 Borger and coworkers3 suggested that patients
undergoing operations for BAV disease should be considered
for concomitant replacement of the ascending aorta if the di-
ameter is 4.5 cm or greater. Recent guidelines from the Amer-
ican College of Cardiology/American Heart Association
confirm such a strategy.16 However, not all patients with
BAV will develop aortic dilatation over time. Nistri and co-
workers17 observed a 52% prevalence of aortic dilatation in
a series of young patients with normally functioning BAV.
Techniques for real-time intraoperative histologic grading
of the aortic wall, requiring less time than standard aortic
valve replacement, are not yet available. Moreover, there is
still limited knowledge about clinical or echocardiographic
features that may help to identify patients with BAV who
are prone to aortic dilatation over time. Novaro and co-
workers18 observed that male gender, sinus diameter, and,
as a trend, right/noncoronary cusp fusion predicted dilation
of the ascending aorta in aortic regurgitation, whereas in aor-
tic stenosis only age and sinus dimension were significant
predictors. However, their study population differs from
ours in that the mean diameter of the mid-ascending aorta
was lower (41.0 mm) and only 18% of patients underwent
replacement of the ascending aorta.
In patients with BAV disease and type A fusion, the pres-
ence of more severe histopathologic features at a younger
age, in addition to a degree of aortic dilatation similar to
that in older patients, and a significantly larger aortic root
suggest a more accelerated and–may be–malignant aortop-
athy. The association with a more severe degree of aortic
disease suggests the opportunity of closer follow-up in
patients with type A BAV.
Limitations
The aim of the study was to investigate aortic disease from
a morphologic point of view. Therefore, our results are not
yet supported by a follow-up to evaluate the clinical effect
of anatomic features on the long-term prognosis. Another
limitation of the study is its retrospective design. BecauseThe Journal of Thorof the low prevalence of type C fusion, we were unable to
make any inference about such fusion pattern. Moreover, aor-
tic diameter was expressed as absolute value. We recognize
that indexing the aortic diameter to the body surface area
could be useful for decision making in patients with excep-
tionally small (,1.6 m2) or large (.2.2 m2) body size. Nev-
ertheless, we did elect to refer to absolute values for the
following reasons: Current clinical practice still refers mainly
to absolute values to evaluate surgical indications, and most
of our patients had a body surface area within normal range
(1.7–2.0 m2). Tissue samples have been harvested only
from the mid-ascending aorta. Therefore, we are unable to
speculate about the topography of the degenerative aortic
changes. The conclusions of our study do not concern the to-
tality of the patients with BAV. In fact, only a few patients
develop aortic dilatation17 and dissection.1 Moreover, our
study population is selected, because it is composed of pa-
tients with both severely diseased BAV and dilated aorta.
Conclusions
In patients with BAV, we observed a statistically significant
association between type A valve anatomy and both a more
severe degree of wall degeneration in the ascending aorta
and dilatation of the aortic root at a younger age than in
type B anatomy. Such evidence supports a closer follow-up
of patients with fusion of the coronary cusps. There is a com-
pelling need for further studies on the relationships among
BAV, aortic wall status, and clinical events to identify pa-
tients at increased risk of aortic complications.
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